Women in all trimesters of pregnancy, and during the immediate postpartum period, who attended The Royal Hospital, Muscat, Oman from March 24 to July 31, 2020, with laboratory‐confirmed severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection were recruited for this study. Real time polymerase chain reaction (RT‐PCR) of nasopharyngeal and oropharyngeal swabs, using the Liferiver® Novel Coronavirus Real Time Multiplex RT‐PCR Kit (Biotechnology Co., Shanghai, China), was used to confirm the diagnosis. Disease severity was assessed using the categories and definitions specified by the US National Institutes of Health COVID‐19 Treatment Guidelines Panel. 2 Data were retrieved from electronic records. For the purpose of statistical analysis, asymptomatic patients, those with mild illness, and those with moderate, severe, or critical illness were categorized as groups 1, 2, and 3, respectively.